The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


GWP GW PHARMACEUTICALS PLC ORD 0.1P

GW PHARM.  Currency  GBX 



 Page 1 of 3

| 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
07:00 14-Apr-2015 GWP New Epidiolex Data Released by AAN RNS +15.31% Up
14:03 01-Apr-2015 GWP Holding(s) in Company RNS +3.19% Up
12:00 31-Mar-2015 GWP Starts Ph 3 Trial for Epidiolex in Dravet Syndrome RNS +3.10% Up
17:18 17-Mar-2015 GWP Holding(s) in Company RNS +9.80% Up
17:15 17-Mar-2015 GWP Holding(s) in Company RNS +9.80% Up
12:00 25-Feb-2015 GWP Presenting at Upcoming Investor Conferences RNS -2.96% Down
15:25 17-Feb-2015 GWP Blocklisting Interim Review RNS +8.93% Up
15:52 16-Feb-2015 GWP Holding(s) in Company RNS +6.96% Up
15:48 16-Feb-2015 GWP Holding(s) in Company RNS +6.96% Up
17:31 09-Feb-2015 GWP Director/PDMR Shareholding RNS +1.71% Up
14:25 05-Feb-2015 GWP Result of AGM RNS +1.58% Up
12:00 05-Feb-2015 GWP Presents at Leerink Global Healthcare Conference RNS +1.58% Up
12:01 04-Feb-2015 GWP 1st Quarter Results RNS -0.54% Down
07:01 27-Jan-2015 GWP Notice of Results RNS -1.26% Down
16:24 09-Jan-2015 GWP Block Listing Application RNS +10.36% Up
12:00 08-Jan-2015 GWP Update on Epidiolex Program RNS +10.84% Up
12:00 08-Jan-2015 GWP Results in Sativex Phase 3 Cancer Pain Trial RNS +10.84% Up
07:00 22-Dec-2014 GWP GW Added to NASDAQ Biotechnology Index RNS -1.92% Down
18:16 17-Dec-2014 GWP Publication of UK Annual Report and Accounts RNS -1.27% Down
16:49 17-Dec-2014 GWP Director/PDMR Shareholding RNS -1.27% Down

 Page 1 of 3

| 1 | 2 | 3 | Next

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released, including the day of the release of the news
y = instrument's latest 7 closing prices before the news was released

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank " - " next to the line indicating the RNS issue.


GW PHARM. share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds